Trust Company’s Lifestance Health LFST Stock Holding History

Trust Company’s Portfolio LFST Stock Details LFST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$696	Hold	65	–	–	﹤0.01%	671
2026 Q1	$414	Hold	65	–	–	﹤0.01%	763
2025 Q4	$458	Buy	+65	New	+$392	﹤0.01%	720

Other funds holding LFST

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Summit Partners Boston, Massachusetts $609M AUM 7.66% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Trust Company's LFST Position: Q2 2026 in Review

Trust Company held its Lifestance Health (LFST) position steady in Q2 2026 at 65 shares worth $696. The position accounts for ﹤0.01% of the portfolio, ranked #671.

Trust Company first reported a position in LFST in Q4 2025 and has held it in 3 quarters since. 287 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

Trust Company held 65 shares of Lifestance Health worth $696 as of Q2 2026.
Trust Company left its Lifestance Health share count unchanged in Q2 2026.
Lifestance Health made up ﹤0.01% of Trust Company's portfolio in Q2 2026, its #671 holding.
Trust Company first reported a position in Lifestance Health in Q4 2025 and has held it in 3 quarters since.
287 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.